Your Article Summary
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer
Gynecologic Oncology, 07/01/09
Havrilesky LJ et al. - Surgically assessed stage IIIA endometrial adenocarcinoma recurs in approximately 20–25% of cases. A subset of stage IIIA1 with very low risk factors may be appropriate candidates for observation.
Related Articles
Endometrial Cancer
American Family Physician, 11/12/09
Relevance Score: 70%
Coffee link to reduced cancer risk
Internet Source, 11/04/09
Relevance Score: 70%
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09
Relevance Score: 69%
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
Relevance Score: 69%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Cancer Research, 12/20/09
Adult-Type Granulosa Cell Tumors and FOXL2 Mutation
Cancer Research, 12/20/09
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
BMC Cancer, 12/20/09

See Latest Articles